| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 341.33B | 347.20B | 349.92B | 301.50B | 241.90B | 204.71B |
| Gross Profit | 52.14B | 52.66B | 50.71B | 35.45B | 32.03B | 29.68B |
| EBITDA | 36.19B | 36.64B | 36.35B | 27.28B | 26.32B | 26.51B |
| Net Income | 6.51B | 7.78B | 7.92B | 2.44B | 5.43B | 7.38B |
Balance Sheet | ||||||
| Total Assets | 287.34B | 285.13B | 290.34B | 269.28B | 259.96B | 226.07B |
| Cash, Cash Equivalents and Short-Term Investments | 38.04B | 34.16B | 26.79B | 26.84B | 28.95B | 25.25B |
| Total Debt | 101.37B | 97.91B | 100.20B | 99.90B | 97.29B | 78.22B |
| Total Liabilities | 165.07B | 161.15B | 164.94B | 154.84B | 147.69B | 130.15B |
| Stockholders Equity | 112.85B | 114.76B | 115.78B | 102.73B | 100.59B | 85.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.86B | 19.00B | 5.12B | -11.01B | 5.74B |
| Operating Cash Flow | 0.00 | 31.92B | 31.64B | 19.41B | 5.80B | 18.26B |
| Investing Cash Flow | 0.00 | -16.10B | -15.99B | -17.93B | -20.13B | -12.20B |
| Financing Cash Flow | 0.00 | -7.74B | -17.75B | -4.51B | 14.76B | -6.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥214.74B | 14.77 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥531.09B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
71 Outperform | ¥278.62B | -8.32 | ― | 1.93% | -1.60% | -71.42% | |
68 Neutral | ¥616.18B | 28.26 | ― | 3.52% | 7.58% | 162.60% | |
66 Neutral | ¥594.33B | 43.48 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.79T | 9.32 | 8.34% | 2.03% | 4.53% | 65.12% |